EGFR and non-small cell lung carcinoma: In this regard, we reviewed relevant literature and found that EPN3 not only exerts oncogenic effects in NSCLC by regulating the EGFR signalling pathway but also exerts similar effects by activating the JAK1/2-STAT3 pathway [34].